Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?
作者信息
Lanteri Marion C, Busch Michael P
出版信息
Transfusion. 2012 Aug;52(8):1634-9. doi: 10.1111/j.1537-2995.2012.03747.x.
Abstract
摘要
相似文献
1
Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?
Transfusion. 2012 Aug;52(8):1634-9. doi: 10.1111/j.1537-2995.2012.03747.x.
2
Dengue, one of the great emerging health challenges of the 21st century.
Expert Rev Vaccines. 2004 Oct;3(5):511-20. doi: 10.1586/14760584.3.5.511.
3
Emerging Infectious Diseases.
Adv Pediatr. 2017 Aug;64(1):27-71. doi: 10.1016/j.yapd.2017.04.002.
4
Dengue and hemorrhagic fever: a potential threat to public health in the United States.
JAMA. 2008 Jan 9;299(2):214-6. doi: 10.1001/jama.2007.31-a.
5
[The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya].
Transfus Clin Biol. 2013 May;20(2):165-73. doi: 10.1016/j.tracli.2013.03.008. Epub 2013 Apr 25.
6
Only screen blood or safe blood management.
J Pak Med Assoc. 2000 Nov;50(11):368-9.
7
Deciphering emerging Zika and dengue viral epidemics: Implications for global maternal-child health burden.
J Infect Public Health. 2016 May-Jun;9(3):240-50. doi: 10.1016/j.jiph.2016.02.005. Epub 2016 Apr 2.
8
Serologic evidence of dengue infection before onset of epidemic, Bangladesh.
Emerg Infect Dis. 2003 Nov;9(11):1411-4. doi: 10.3201/eid0911.030117.
9
Maintaining a Safe Blood Supply in an Era of Emerging Pathogens.
J Infect Dis. 2016 Jun 1;213(11):1676-7. doi: 10.1093/infdis/jiw089. Epub 2016 Mar 8.
10
Failed screen test audit.
Transfus Med. 2002 Feb;12(1):79-80. doi: 10.1046/j.1365-3148.2002.03442.x.
引用本文的文献
1
Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission.
Lancet Reg Health Eur. 2025 Apr 4;53:101271. doi: 10.1016/j.lanepe.2025.101271. eCollection 2025 Jun.
2
Neurological Manifestations of Perinatal Dengue.
Newborn (Clarksville). 2023;2(2):158-172. doi: 10.5005/jp-journals-11002-0066. Epub 2023 May 7.
3
Assessment of dengue virus threat to blood safety and community health: A single center study in northern Egypt.
J Virus Erad. 2022 Jun 27;8(2):100077. doi: 10.1016/j.jve.2022.100077. eCollection 2022 Jun.
4
Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.
Transfusion. 2022 Jul;62(7):1388-1398. doi: 10.1111/trf.16950. Epub 2022 Jun 21.
5
Prevalence of dengue NS1 antigenemia among healthy blood donors in a tertiary care hospital in Southern India.
Asian J Transfus Sci. 2021 Jul-Dec;15(2):140-145. doi: 10.4103/ajts.ajts_51_21. Epub 2021 Nov 1.
6
Dengue virus infection among renal transplant recipients in Singapore: a 15-year, single-centre retrospective review.
Singapore Med J. 2024 Apr 1;65(4):235-241. doi: 10.11622/smedj.2021167. Epub 2021 Nov 8.
7
Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia.
Transfusion. 2021 Jan;61(1):134-143. doi: 10.1111/trf.16110. Epub 2020 Oct 7.
8
Dengue Virus Infection of Blood-Brain Barrier Cells: Consequences of Severe Disease.
Front Microbiol. 2019 Jun 26;10:1435. doi: 10.3389/fmicb.2019.01435. eCollection 2019.
9
Prevalence of Zika virus in blood donations: a systematic review and meta-analysis.
BMC Infect Dis. 2019 Jul 6;19(1):590. doi: 10.1186/s12879-019-4226-6.
10
Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review.
Braz J Infect Dis. 2018 Jan-Feb;22(1):63-69. doi: 10.1016/j.bjid.2018.01.001. Epub 2018 Jan 19.
本文引用的文献
1
Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop.
Transfusion. 2013 Feb;53(2):455-63. doi: 10.1111/j.1537-2995.2012.03808.x. Epub 2012 Jul 31.
2
Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
Transfusion. 2013 Feb;53(2):438-54. doi: 10.1111/j.1537-2995.2012.03742.x. Epub 2012 Jun 13.
3
Detection of dengue virus in sera of Brazilian blood donors.
Transfusion. 2012 Aug;52(8):1667-71. doi: 10.1111/j.1537-2995.2012.03729.x. Epub 2012 Jun 7.
4
Dengue.
N Engl J Med. 2012 Apr 12;366(15):1423-32. doi: 10.1056/NEJMra1110265.
5
Good evidence begets good policy: or so it should be.
Transfusion. 2012 Mar;52(3):463-5. doi: 10.1111/j.1537-2995.2012.03560.x.
6
Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico.
Transfusion. 2012 Aug;52(8):1657-66. doi: 10.1111/j.1537-2995.2012.03566.x. Epub 2012 Feb 17.
7
Phylogeography and population dynamics of dengue viruses in the Americas.
Mol Biol Evol. 2012 Jun;29(6):1533-43. doi: 10.1093/molbev/msr320. Epub 2012 Jan 6.
8
Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010.
Transfusion. 2012 Aug;52(8):1647-51. doi: 10.1111/j.1537-2995.2011.03529.x. Epub 2012 Feb 5.
9
How can the blood transfusion medicine community contribute to public health in tough economic times?
J Infect Dis. 2012 Mar 15;205(6):867-9. doi: 10.1093/infdis/jir866. Epub 2012 Jan 31.
10
Dengue outbreak in Key West, Florida, USA, 2009.
Emerg Infect Dis. 2012 Jan;18(1):135-7. doi: 10.3201/eid1801.110130.
Zotero 插件